Groove Botanicals (GRVE) Equity Average (2011 - 2025)

Groove Botanicals has disclosed Equity Average across 11 years of filings, most recently posting -$1.3 million for Q4 2025.

• Equity Average for Q4 2025 came in at -$1.3 million, down 36.11% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.3 million (down 36.11% YoY), and the FY2025 annual result was -$935209.0, down 56.02% from the prior year.
• Equity Average came in at -$1.3 million for Q4 2025 at Groove Botanicals, down from -$1.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$479590.5 in Q1 2023 to a low of -$1.3 million in Q4 2025.
• The 4-year median for Equity Average is -$818448.0 (2022), against an average of -$838034.5.
• Across the five-year window, Equity Average advanced 29.8% in 2023 and slumped 64.66% in 2024, its largest moves.
• Groove Botanicals' Equity Average stood at -$526837.0 in 2022, then dropped by 20.7% to -$635915.5 in 2023, then sank by 54.11% to -$979988.5 in 2024, then sank by 36.11% to -$1.3 million in 2025.
• The last three Equity Average figures came in at -$1.3 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.2 million (Q2 2025), per Business Quant data.